Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexiaC L Loprinzi, J C Michalak, D J Schaid, et al.
The New England Journal of Medicine|August 11, 1994
Megestrol acetate for the prevention of hot flashesC L Loprinzi, J C Michalak, S K Quella, et al.
Cancer|October 1, 1993
A randomized clinical trial of two different durations of oral cryotherapy for prevention of 5-fluorouracil-related stomatitisL K Rocke, C L Loprinzi, J K Lee, et al.
Lung Cancer (Amsterdam, Netherlands)|March 16, 2000
A randomized phase II trial of two schedules of topotecan for the treatment of advanced stage non-small cell lung cancerJ J Weitz, R F Marschke, J A Sloan, et al.
American Journal of Clinical Oncology|October 22, 1998
A phase II study of high-dose cimetidine and the combination 5-fluorouracil, interferon alpha-2A, and leucovorin in advanced renal cell adenocarcinomaE T Creagan, M H Veeder, V J Suman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2000
Phase III evaluation of octreotide versus chemotherapy with 5-fluorouracil or 5-fluorouracil plus leucovorin in advanced exocrine pancreatic cancer: a North Central Cancer Treatment Group studyP A Burch, M Block, G Schroeder, et al.
Cancer|May 1, 1994
Randomized trial of cyclophosphamide, methotrexate, and 5-fluorouracil with or without estrogenic recruitment in women with metastatic breast cancerJ N Ingle, J F Foley, J A Mailliard, et al.
Cancer|July 15, 1997
A randomized phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinomaJ N Ingle, P A Johnson, V J Suman, et al.
Cancer|May 1, 1993
A randomized phase II trial of amonafide or trimetrexate in patients with advanced non-small cell lung cancer. A trial of the North Central Cancer Treatment GroupD H Gesme, J R Jett, D D Schreffler, et al.
Cancer|January 5, 2000
A phase II study of paclitaxel plus carboplatin as first-line chemotherapy for women with metastatic breast carcinomaE A Perez, D W Hillman, P J Stella, et al.
Pageof 3